Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | 23,408,817 | reported | 13 Oct 2020 | tx 2+54,117,287 |
| Axcella Health Inc. | 11,105,438 | reported | 13 Oct 2022 | tx 3+11,105,438 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Oct 2022 | PURCHASE | Axcella Health Inc. | 3,658,536 | 1.64 USD | |
| 16 Mar 2022 | PURCHASE | Axcella Health Inc. | 3,141,361 | 1.91 USD | first after silence |
| 13 Oct 2020 | PURCHASE | Aimmune Therapeutics, Inc. | 43,435,583 | 34.50 USD | |
| 13 Oct 2020 | PURCHASE | Aimmune Therapeutics, Inc. | 10,681,704 | 34.50 USD | |
| 08 Sept 2020 | OTHER | Axcella Health Inc. | 4,305,541 | 4.42 USD |
1 purchase reported after at least 12 months of silence — most recent on 16 Mar 2022.